Impact of renal function on bleeding risk in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: Subanalysis of the DIRECT registry

被引：0
|
作者：
Hirata, A. [1 ]
Sotomi, Y. [1 ]
Kobayashi, T. [1 ]
Amiya, R. [1 ]
Hirayama, A. [1 ]
Higuchi, Y. [1 ]
机构：
[1] Osaka Police Hosp, Cardiovasc Div, Osaka, Japan
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4753
引用
收藏
页码：2957 / 2957
页数：1
相关论文
共 50 条
  • [31] Inappropriate low dosing of direct oral anticoagulants in older patients with non-valvular atrial fibrillation: Impact on plasma drug levels
    Comans, Anne-Lore
    Sennesael, Anne-Laure
    Bihin, Benoit
    Regnier, Maxime
    Mullier, Francois
    Saint-Hubert, Marie de
    THROMBOSIS RESEARCH, 2021, 201 : 139 - 142
  • [32] Direct oral anticoagulants in patients with cardiac implantable devices and non-valvular atrial fibrillation: the complexity of dose adjustments and the impact on outcomes
    Santos, J. M.
    Mendes, A. R.
    Rocha, M. J.
    Goncalves, L.
    Antonio, N.
    Fortuna, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 : 47 - 47
  • [33] Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
    Cunha, Pedro Silva
    Monteiro, Andre Viveiros
    Cruz, Madalena Coutinho
    Malveiro, Paula
    Reis, Joao Pedro
    Portugal, Guilherme
    Dias, Ana
    Ferreira, Rui Cruz
    Oliveira, Mario Martins
    GERIATRICS, 2022, 7 (01)
  • [34] Risk of fracture in patients with non-valvular atrial fibrillation initiating direct oral anticoagulants vs. vitamin K antagonists
    He, Na
    Dell'Aniello, Sophie
    Zhai, Suodi
    Suissa, Samy
    Renoux, Christel
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 389 - 397
  • [35] Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
    Yamato, Hiroshi
    Abe, Koichiro
    Osumi, Shun
    Yanagisawa, Daisuke
    Kodashima, Shinya
    Asaoka, Yoshinari
    Konno, Kumiko
    Kozuma, Ken
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [36] Comparative Outcomes of Direct Oral Anticoagulants versus Warfarin in Morbidly Obese Patients With Non-valvular Atrial Fibrillation
    Barakat, Amr F.
    Jain, Sandeep
    Masri, Ahmad
    Senussi, Mourad
    Wang, Yisi
    Bhonsale, Aditya
    Saba, Samir
    Mulukutla, Suresh R.
    CIRCULATION, 2019, 140
  • [37] Real-world persistence with direct oral anticoagulants (DOACs) in naive patients with non-valvular atrial fibrillation
    Ferroni, Eliana
    Gennaro, Nicola
    Costa, Giorgio
    Fedeli, Ugo
    Denas, Gentian
    Pengo, Vittorio
    Corti, Maria Chiara
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 288 : 72 - 75
  • [38] Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation
    Yanagisawa, Daisuke
    Abe, Koichiro
    Amano, Hirohito
    Komatsuda, Shogo
    Honda, Taku
    Manabe, Daisuke
    Yamamoto, Hirosada
    Kozuma, Ken
    Kodashima, Shinya
    Asaoka, Yoshinari
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    PLOS ONE, 2021, 16 (11):
  • [39] Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation
    Saliba, Layla
    Mondoly, Pierre
    Duparc, Alexandre
    Bura-Riviere, Alessandra
    Maury, Philippe
    Calmels, Violaine
    Sallerin, Brigitte
    Pathak, Atul
    Montastruc, Jean-Louis
    Bagheri, Haleh
    THERAPIE, 2015, 70 (06): : 485 - 492
  • [40] Direct oral anticoagulants: medication dosing errors in hospitalized patients with non-valvular atrial fibrillation and heart failure
    Cabello Montoya, F.
    Zambrano Del Valle, S.
    Stavtseva, Y.
    Kobalava, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 9 - 9
12345